122 related articles for article (PubMed ID: 1536795)
21. [The Philadelphia chromosome 30 years later].
Lisker R
Rev Invest Clin; 1992; 44(1):123-30. PubMed ID: 1523343
[TBL] [Abstract][Full Text] [Related]
22. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
[TBL] [Abstract][Full Text] [Related]
23. Prediction of clinical relapse after bone-marrow transplantation by PCR for Philadelphia-positive acute lymphoblastic leukaemia.
Miyamura K; Morishima Y; Tanimoto M; Saito H; Kojima S; Kodera Y; Mizutani S
Lancet; 1990 Oct; 336(8719):890. PubMed ID: 1976927
[No Abstract] [Full Text] [Related]
24. Lineage switch in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Reardon DA; Hanson CA; Roth MS; Castle VP
Cancer; 1994 Mar; 73(5):1526-32. PubMed ID: 8111722
[TBL] [Abstract][Full Text] [Related]
25. Breakpoint cluster region (BCR) gene rearrangement studies in chronic myeloid and acute lymphoblastic leukemias.
Chin YM; Bosco JJ; Koh CL
Med J Malaysia; 1992 Jun; 47(2):110-3. PubMed ID: 1494330
[TBL] [Abstract][Full Text] [Related]
26. [The molecular biology diagnosis of neoplastic blood diseases].
Teleheiev HD; Dybkov MV; Bozhko MV; Tretiak NM; Maliuta SS
Tsitol Genet; 1998; 32(1):71-8. PubMed ID: 9695255
[TBL] [Abstract][Full Text] [Related]
27. Philadelphia chromosome-positive leukemia: molecular analysis of bcr and abl genes and transforming genes.
Okabe M; Matsushima S
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1471-80. PubMed ID: 3247820
[No Abstract] [Full Text] [Related]
28. [Detection on BCR-ABL fusion gene in Ph1 chromosome positive leukemia by "nested" retrotranscriptase/polymerase chain reaction].
Huang W; Cao Q; Lu Y
Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):662-5, 708. PubMed ID: 7866899
[TBL] [Abstract][Full Text] [Related]
29. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia.
Kirk JA; Radich J; Edmands S; Lee A; VanDevanter DR; Reems JA; Bryant EM
Am J Hematol; 1996 Jul; 52(3):129-34. PubMed ID: 8756076
[TBL] [Abstract][Full Text] [Related]
30. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
Kolenova A; Maloney KW; Hunger SP
J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
[TBL] [Abstract][Full Text] [Related]
31. Re-emerging Philadelphia chromosome-positive acute leukaemia more than 20 years after allogeneic haematopoietic stem cell transplantation.
Kodama Y; Okamura J; Fukano R; Nakashima K; Ito N; Nishimura M; Abe Y; Suzuki T; Inagaki J
Br J Haematol; 2013 Apr; 161(2):286-9. PubMed ID: 23294201
[No Abstract] [Full Text] [Related]
32. [Bcr-abl translocation: diagnostic methods and clinical value].
Pignon JM
Ann Biol Clin (Paris); 1998; 56(1):57-63. PubMed ID: 9754223
[TBL] [Abstract][Full Text] [Related]
33. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
34. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
[TBL] [Abstract][Full Text] [Related]
35. Expression patterns of WT-1 and Bcr-Abl measured by TaqMan quantitative real-time RT-PCR during follow-up of leukemia patients with the Ph chromosome.
Chen ZX; Kaeda J; Saunders S; Goldman JM
Chin Med J (Engl); 2004 Jul; 117(7):968-71. PubMed ID: 15265366
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of BCR-ABL leukemogenesis and novel targets for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
Platanias LC
Leuk Lymphoma; 2011 Feb; 52 Suppl 1():2-3. PubMed ID: 21208039
[No Abstract] [Full Text] [Related]
37. Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission.
Cherrier-De Wilde S; Rack K; Vannuffel P; Delannoy A; Hagemeijer A
Leukemia; 2003 Oct; 17(10):2046-8. PubMed ID: 14513056
[No Abstract] [Full Text] [Related]
38. Hemizygous deletion of the 3' end of the RB1 gene in a case of Philadelphia positive-acute lymphoblastic leukemia.
Hillion J; Larsen CJ; Berger R
Cancer Genet Cytogenet; 1991 Jul; 54(2):197-203. PubMed ID: 1884351
[TBL] [Abstract][Full Text] [Related]
39. [Molecular construction of Philadelphia chromosome and its relation to the clinical features].
Kamada N; Tanaka K; Asou H
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1098-105. PubMed ID: 2053768
[TBL] [Abstract][Full Text] [Related]
40. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
